Abstract:Natural aglycones, a major ingredient accompanied by glycosides in plants, have played an important role in the treatment of various diseases. However, their bioavailability is limited by their poor water solubility. In contrast to previous efforts that required the use of new exotic materials which may raise concerns about biocompatibility, we report the first case of excipient-free nanodispersions in which an insoluble glycyrrhetinic acid (GA) assembled with its amphiphilic parent drug diammonium glycyrrhizinate (DG) into water-dispersible nanodispersions (130.8 nm for particle size and 91.74% for encapsulation efficiency). This strategy largely increased GA's water apparent solubility by hundreds of times to 549.0 mu g/mL with a high cumulative dissolution percentage in vitro greater than 80% in 5 min. The study on the formation mechanism showed that the OH, C-O and C=O group stretching peaks shifted in the FTIR spectra of GA-DG nanodispersions, while the COOH peak (delta COOH 12.19 ppm) disappeared in the 1H NMR spectrum of GA-DG nanodispersions, indicating that carboxyl groups on GA may interact with the hydroxyl groups of DG in solution. Molecular dynamics simulations suggested that both hydrophobic interactions and hydrogen-bond interactions contribute to the coassembly of GA and DG molecules in aqueous solution. Oral pharmacokinetic studies in rats demonstrated that such nanodispersions have a significant increase in Cmax and AUC0-t of 2.45- and 3.45-fold compared with those for GA, respectively. Therefore, this strategy, employing amphiphilic glycosides as excipients to prepare nanodispersions, not using new materials, paves the way for the further application of hydrophobic aglycone drugs.

Representation and in vitro transdermal characteristics of glycyrrhizic acid nanoparticles prepared by antisolvent recrystallization method

Engineering of Ganoderma lucidum polysaccharide loaded polyvinyl alcohol nanofibers for biopharmaceutical delivery

Preparation and transdermal delivery of glycyrrhetinic acid loaded solid lipid nanoparticle gels

Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.

Nanosuspensions As Delivery System for Gambogenic Acid: Characterization and in Vitro/in Vivo Evaluation

Excipient-free Nanodispersions Dominated by Amphiphilic Glycosides for Bioavailability Enhancement of Hydrophobic Aglycones, a Case of Glycyrrhetinic Acid with Diammonium Glycyrrhizinate.

Enhanced Oral Bioavailability of Glycyrrhetinic Acid Via Nanocrystal Formulation

The Development of Novel Ganoderic-Acid-Encapsulated Nanodispersions Using the Combination of Ultrasonic Cavitation and Solvent Evaporation through Response Surface Optimization

Study on the Preparation and in Vitro Properties of Glycyrrhetinic Acid Long-circulating Solid Lipid Nanoparticles

Preparation and in Vitro Percutaneous Permeation Profile of Glycyrrhetinic Acid Ethosome Hydrogel Patch

Preparation, Characterization, and Drug Release in Vitro of Chitosan-Glycyrrhetic Acid Nanoparticles.

Hepatic targeting of glycyrrhetinic acid via nanomicelles based on stearic acid-modified fenugreek gum

Preparation, characterization and pharmacokinetic studies of total paeony glycoside nanocrystals

Response Surface Optimisation for the Development of Novel Ganoderic Acid Encapsulated Nanodispersions Using the Combination of Ultrasonic Cavitation and Solvent Evaporation Strategies

Optimization, characterization and evaluation of sodium alginate nanoparticles for Ganoderic acid DM encapsulation: Inhibitory activity on tyrosinase activity and melanin formation

Nanocrystallization of the Pharmaceutically Active Agent Genipin by an Emulsion Solvent Evaporation Method

Comparative study on effects of GA nanoparticles suspension and unprocessed GA solution on oral bioavailability, hepatic function and liver antioxidant enzymes activities in carbon tetrachloride-induced liver damage rats

Synthesis, Characterization and Bioactivity Evaluation of a Novel Nano Bagasse Xylan/Andrographolide Grafted and Esterified Derivative

Preparation and Percutaneous Absorption in Vitro of Ruanganxiaoshui Cataplasma

Simplified Gambogic Acid Prodrug Nanoparticles to Improve Efficiency and Reduce Toxicity for Clinical Translation Potential

Preparation of N-caproyl Chitosan Nanoparticles Surface-modified with Glycyrrhizin and Its Stability in Vitro